$CADL

$7.79 -$0.24 (2.99%) Close

$CADL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$CADL Management Team

Mr. Paul Manning

Chairman of the Board

Age 65

Compensation -

Sex Male

Dr. Paul Tak

President

Chief Executive Officer

Director

Age -

Compensation -

Sex Male

Dr. Estuardo Aguilar- Cordova

Co-Founder

Chief Scientific Officer

Director

Age -

Compensation -

Sex Male

Mr. John Canepa

Chief Financial Officer

Age -

Compensation -

Sex Male

Dr. Laura Aguilar

Chief Medical Officer

Age -

Compensation -

Sex Female

Mr. Daniel Giroux

Vice President - Manufacturing

Age -

Compensation -

Sex Male

Mr. Stephen Rocamboli

Chief Business Officer

Age 42

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Paul Manning Chairman of the Board	65	-	Male
Dr. Paul Tak President Chief Executive Officer Director	-	-	Male
Dr. Estuardo Aguilar- Cordova Co-Founder Chief Scientific Officer Director	-	-	Male
Mr. John Canepa Chief Financial Officer	-	-	Male
Dr. Laura Aguilar Chief Medical Officer	-	-	Female
Mr. Daniel Giroux Vice President - Manufacturing	-	-	Male
Mr. Stephen Rocamboli Chief Business Officer	42	-	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

5.2 years

from year joined

CEO also chairs the board

Paul B. Manning

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Edward J. Benz, Jr.	79	2017 9 years	Not stated	Nominating and Corporate Governance Committee · Chair	None stated	$103,546
Paul B. Manning Board chair	70	2018 8 years	Not stated	Compensation Committee	Liquidia Corporation	$130,546
Maha Radhakrishnan, M.D.	56	2025 1 year	Not stated	Audit Committee	Entrada Therapeutics, Inc.	$158,346
Paul Peter Tak, M.D., Ph.D., FMedSci CEO	66	2020 6 years	Not stated	None stated	None stated	Paid as CEO
Renee Gaeta	45	2022 4 years	Not stated	None stated	None stated	$103,046
Gary J. Nabel, M.D., Ph.D.	72	2022 4 years	Not stated	Nominating and Corporate Governance Committee	Siga Technologies, Inc.	$99,546
Joseph C. Papa, R.Ph., M.B.A.	70	2022 4 years	Not stated	Compensation Committee	Prometheus Biosciences, Inc.	$101,810
Nicoletta Loggia, Ph.D., R.Ph.	58	2023 3 years	Not stated	None stated	None stated	$107,019
Christopher Martell	47	2018 8 years	Not stated	Nominating and Corporate Governance Committee	None stated	$114,546
Diem Nguyen, Ph.D.	54	2021 5 years	Not stated	Compensation Committee	Verrica Pharmaceuticals Inc.	$104,310

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$CADL Management Team

Mr. Paul Manning

Dr. Paul Tak

Dr. Estuardo Aguilar- Cordova

Mr. John Canepa

Dr. Laura Aguilar

Mr. Daniel Giroux

Mr. Stephen Rocamboli

Board of Directors

Related-party transactions

No related-party transactions disclosed